NasdaqGM - Delayed Quote USD
Translational Development Acquisition Corp. (TDACU)
10.32
-0.04
(-0.39%)
At close: June 2 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
Total Revenue
0
0
0
Operating Expense
543.77
196.36
485.55
Operating Income
-543.77
-196.36
-485.55
Other Income Expense
--
125.35
--
Pretax Income
1,412.06
-71.01
-485.55
Net Income Common Stockholders
1,412.06
-71.01
-485.55
Diluted NI Available to Com Stockholders
1,412.06
-71.01
-485.55
Total Operating Income as Reported
-543.77
-196.36
-485.55
Total Expenses
543.77
196.36
485.55
Net Income from Continuing & Discontinued Operation
1,412.06
-71.01
-485.55
Normalized Income
-133.04
-196.36
-485.55
EBIT
-543.77
-196.36
-485.55
EBITDA
-543.77
-196.36
-485.55
Net Income from Continuing Operation Net Minority Interest
1,412.06
-71.01
-485.55
Total Unusual Items Excluding Goodwill
1,955.83
125.35
--
Total Unusual Items
1,955.83
125.35
--
Normalized EBITDA
-2,499.59
-321.70
-485.55
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
410.72
0
0
12/31/2023 - 12/23/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade